Pliant Therapeutics, Inc. (PLRX) Financials
PLRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 202.6 million | 37.4 million |
| Dec. 31, 2025 | 225.2 million | 44.0 million |
| Sept. 30, 2025 | 276.6 million | 76.3 million |
| June 30, 2025 | 299.8 million | 79.7 million |
PLRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -19.2 million | 4.3 million |
| Dec. 31, 2025 | -17.8 million | 4.5 million |
| Sept. 30, 2025 | -21.1 million | 6.4 million |
| June 30, 2025 | -40.7 million | 6.4 million |
PLRX Net Income
No data available :(
PLRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 170.9 million | - | 27.1 million |
| Dec. 31, 2025 | 190.9 million | - | 29.1 million |
| Sept. 30, 2025 | 241.8 million | 30.4 million | 29.4 million |
| June 30, 2025 | 262.9 million | 30.4 million | 30.0 million |
PLRX Shares Outstanding
PLRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 13.3 million | 8.2 million | - |
| Dec. 31, 2025 | - | 15.6 million | 8.0 million | - |
| Sept. 30, 2025 | - | 17.9 million | 10.3 million | - |
| June 30, 2025 | 112000 | 32.2 million | 13.4 million | - |
PLRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 264000 |
| Dec. 31, 2025 | - | 365000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 447000 |
PLRX
Price: $1.18
52 week price:
Earnings Per Share: -1.83 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Market Capitalization: 71.2 million